Search
for
Sort by
Research 361–390 of 470
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Shortcutting the diagnostic odyssey: the multidisciplinary Program for Undiagnosed Rare Diseases in adults (UD-PrOZA)
- Upper gastrointestinal bleeding during the COVID-19 pandemic; particularities of diagnosis and therapy
- Rash morphology as a predictor of COVID‐19 severity: A systematic review of the cutaneous manifestations of COVID‐19
- Persistent Post COVID-19 Symptoms and Functional Status after 12-14 weeks of recovery, Tamil Nadu, India, 2021
- Interstitial pneumonia with autoimmune features: challenges and controversies
- Treatment Response to Conventional and Novel Therapies in Chronic Prostatitis
- Mechanisms of autophagy and their implications in dermatological disorders
- The Silent Syndrome of Long COVID and Gaps in Scientific Knowledge: A Narrative Review
- Comparing the frequency of isotretinoin-induced hair loss at <0.5-mg/kg/d versus ≥0.5-mg/kg/d dosing in acne patients: A systematic review
- Improving Quality of Life During Chemotherapy: Cannabinoids, Cryotherapy, and Scalp Cooling
- Retinoids in Dermatology
- A Phase 1, Open‐Label Study of the Pharmacokinetics of Ritlecitinib in Children Aged 6–12 Years With Alopecia Areata
- Monkeypox: A Histopathological and Transmission Electron Microscopy Study
- Treatment of lipomas and diffuse lipomatosis with NDYAG 1064 NM laser and their impact on the quality of life
- Refractory dermatomyositis–systemic lupus erythematosus overlap syndrome and response to tofacitinib
- Spectrum and Impact of Reported Side Effects of Omalizumab in Patients With Chronic Urticaria: A Long‐Term Multicentre Real‐World Study
- Impact of anticancer therapy on the quality of life of Sudanese patients with breast cancer at Khartoum oncology hospital
- COVID-19: The question of genetic diversity and therapeutic intervention approaches
- Post-COVID-19 syndrome and quality of life impairment in severe COVID-19 Mexican patients
- Update on Outcome Measures for Pediatric Systemic Lupus Erythematosus
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Cytokine-Targeting Biologic Therapies for Alopecia Areata: A Comprehensive Review of Mechanism of Action, Clinical Efficacy, and Adverse Events
- Exercise in the management of polycystic ovary syndrome: A position statement from Exercise and Sports Science Australia
- Medical Dermatology
- Suspected adverse reactions to medications and food supplements containing <i>Serenoa repens</i>: A worldwide analysis of pharmacovigilance and phytovigilance spontaneous reports
- Persistent or new symptoms 1 year after a single high dose of vitamin D3 in patients with moderate to severe COVID-19
- Essential Oils and Melatonin as Functional Ingredients in Dogs
- Increased risk of chronic fatigue and hair loss following COVID-19 in individuals with hypohidrotic ectodermal dysplasia
- Successful plasmapheresis and immunoglobulin treatment for severe lipid storage myopathy: Doing the right thing for the wrong reason